UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows From Operating Activities:
Net earnings	$ 27,051	$ 27,128
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	11,801	8,706
Reserves for credit losses, inventory obsolescence and sales returns	250	(97)
Share-based compensation expense	2,965	2,495
Excess tax benefit from exercise of stock options	(1,366)	(1,390)
Deferred taxes	(278)	(5)
Payments from lessees directly to lenders-operating leases	(5,857)	(3,799)
Gain on disposal of property, equipment and operating lease equipment	(1,550)	(843)
Gain on sale of notes receivable	(5,707)	(1,002)
Excess increase in cash value of life insurance	(39)	(137)
Other	109	(7)
Changes in:
Accounts receivable - trade	(39,585)	(42,412)
Accounts receivable - other	(3,599)	(4,648)
Notes receivable	282	(502)
Inventories	(9,182)	(629)
Investment in direct financing and sale-type leases-net	(20,406)	11,163
Deferred costs, other assets, and other assets	(410)	(34,043)
Accounts payable-equipment	2,453	(8,294)
Accounts payable-trade	10,816	26,744
Salaries and commissions payable, deferred revenue and accrued expenses and other liabilities	5,486	35,356
Net cash (used in) provided by operating activities	(26,766)	13,784
Cash Flows From Investing Activities:
Purchases of short-term investments	0	(1,233)
Maturities of short-term investments	982	7,401
Proceeds from sale of property, equipment and operating lease equipment	3,280	1,629
Purchases of property, equipment and operating lease equipment	(7,938)	(12,559)
Purchases of assets to be leased	(8,278)	0
Issuance of notes receivable	(68,033)	(32,917)
Repayments of notes receivable	33,497	13,977
Proceeds from sale or transfer of notes receivable	28,270	22,829
Premiums paid on life insurance	(163)	(60)
Cash used in acquisition, net of cash acquired	(2,845)	0
Net cash (used in) investing activities	(21,228)	(933)
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	29,020	20,234
Repayments of non-recourse and recourse notes payable	(2,247)	(641)
Repurchase of common stock	(10,308)	(1,890)
Dividends paid	(107)	(20,100)
Proceeds from issuance of capital stock through option exercise	559	1,167
Payments of contingent consideration	(1,027)	(473)
Excess tax benefit from share based compensation	1,366	1,390
Net borrowings (repayments) on floor plan facility	18,510	(4,164)
Net cash provided by (used in) financing activities	35,766	(4,477)
Effect of exchange rate changes on cash	6	1
Net Increase in Cash and Cash Equivalents	(12,222)	8,375
Cash and Cash Equivalents, Beginning of Period	52,720	33,778
Cash and Cash Equivalents, End of Period	40,498	42,153
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	100	15
Cash paid for income taxes	16,769	19,000
Schedule of Non-Cash Investing and Financing Activities:
Purchase of property and equipment included in accounts payable	75	153
Purchase of operating lease equipment included in accounts payable	308	175
Purchase of assets financed as notes receivables included in accounts payable	3,997	0
Proceeds from sales of operating lease equipment included in accounts receivable	10	50
Repayments of non-recourse and recourse notes payable	15,147	11,374
Dividends declared included in accrued expenses and other liabilities	0	278
Vesting of share-based compensation	7,804	4,621
Origination and concurrent sale of notes receivable	$ 102,131	$ 0